Issue 2, 2012

3-Substituted coumarins as dual inhibitors of AChE and MAO for the treatment of Alzheimer's disease

Abstract

The complex etiology of Alzheimer's disease (AD) has encouraged active research in the development of multi-target drugs with two or more complementary biological activities, since they may represent an important advance in the treatment of this disease. A series of 3-substituted coumarins were synthesized and evaluated as monoamino oxidases (MAO) and acetylcholinesterase (AChE) inhibitors. Most of the 3-benzamide coumarin derivatives inhibited both MAO-B and AChE with values in the micromolar range. It might be a promising direction for developing novel drugs as potential agents for the treatment of AD patients.

Graphical abstract: 3-Substituted coumarins as dual inhibitors of AChE and MAO for the treatment of Alzheimer's disease

Article information

Article type
Concise Article
Submitted
30 Aug 2011
Accepted
03 Oct 2011
First published
26 Oct 2011

Med. Chem. Commun., 2012,3, 213-218

3-Substituted coumarins as dual inhibitors of AChE and MAO for the treatment of Alzheimer's disease

D. Viña, M. J. Matos, M. Yáñez, L. Santana and E. Uriarte, Med. Chem. Commun., 2012, 3, 213 DOI: 10.1039/C1MD00221J

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements